Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy J Furlong

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
AIDS (London, England)|January 2, 2007
Efavirenz-associated podocyte damageThomas D Barbour, Timothy J Furlong, Robert J Finlayson
The Medical Journal of Australia|July 16, 2015
Febuxostat-associated rhabdomyolysis in chronic renal failureDebasish Ghosh, Philippa M McGann, Timothy J Furlong, et al.
BMJ Case Reports|June 8, 2012
Successful use of allopurinol in a patient on dialysisRichard Osborne Day, Diluk Romesh Wijekoon Kannangara, James M Hayes, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 30, 2018
Population data improves variant interpretation in autosomal dominant polycystic kidney diseaseAmali C Mallawaarachchi, Timothy J Furlong, John Shine, et al.
The Medical Journal of Australia|August 3, 2011
Acute glomerulonephritis in a child with multidrug-resistant tuberculosis and multibacillary leprosyLachlan J McIver, Shaun T Parish, Samuel P Jones, et al.
British Journal of Clinical Pharmacology|November 22, 2011
Oxypurinol, allopurinol and allopurinol-1-riboside in plasma following an acute overdose of allopurinol in a patient with advanced chronic kidney diseaseDiluk R W Kannangara, Darren M Roberts, Timothy J Furlong, et al.
European Journal of Human Genetics : EJHG|May 12, 2016
Whole-genome sequencing overcomes pseudogene homology to diagnose autosomal dominant polycystic kidney diseaseAmali C Mallawaarachchi, Yvonne Hort, Mark J Cowley, et al.
Drug Safety|April 4, 2013
The Role of Metformin in Metformin-Associated Lactic Acidosis (MALA): Case Series and Formulation of a Model of PathogenesisJanna K Duong, Timothy J Furlong, Darren M Roberts, et al.
Diabetes, Obesity & Metabolism|October 14, 2016
Could metformin be used in patients with advanced chronic kidney disease?Shaun S Kumar, Garry G Graham, Felicity C Smith, et al.
British Journal of Clinical Pharmacology|October 8, 2014
The pharmacokinetics of metformin and concentrations of haemoglobin A1C and lactate in Indigenous and non-Indigenous Australians with type 2 diabetes mellitusJanna K Duong, Shaun S Kumar, Timothy J Furlong, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
AIDS (London, England)|January 2, 2007
Efavirenz-associated podocyte damageThomas D Barbour, Timothy J Furlong, Robert J Finlayson
The Medical Journal of Australia|July 16, 2015
Febuxostat-associated rhabdomyolysis in chronic renal failureDebasish Ghosh, Philippa M McGann, Timothy J Furlong, et al.
BMJ Case Reports|June 8, 2012
Successful use of allopurinol in a patient on dialysisRichard Osborne Day, Diluk Romesh Wijekoon Kannangara, James M Hayes, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 30, 2018
Population data improves variant interpretation in autosomal dominant polycystic kidney diseaseAmali C Mallawaarachchi, Timothy J Furlong, John Shine, et al.
The Medical Journal of Australia|August 3, 2011
Acute glomerulonephritis in a child with multidrug-resistant tuberculosis and multibacillary leprosyLachlan J McIver, Shaun T Parish, Samuel P Jones, et al.
British Journal of Clinical Pharmacology|November 22, 2011
Oxypurinol, allopurinol and allopurinol-1-riboside in plasma following an acute overdose of allopurinol in a patient with advanced chronic kidney diseaseDiluk R W Kannangara, Darren M Roberts, Timothy J Furlong, et al.
European Journal of Human Genetics : EJHG|May 12, 2016
Whole-genome sequencing overcomes pseudogene homology to diagnose autosomal dominant polycystic kidney diseaseAmali C Mallawaarachchi, Yvonne Hort, Mark J Cowley, et al.
Drug Safety|April 4, 2013
The Role of Metformin in Metformin-Associated Lactic Acidosis (MALA): Case Series and Formulation of a Model of PathogenesisJanna K Duong, Timothy J Furlong, Darren M Roberts, et al.
Diabetes, Obesity & Metabolism|October 14, 2016
Could metformin be used in patients with advanced chronic kidney disease?Shaun S Kumar, Garry G Graham, Felicity C Smith, et al.
British Journal of Clinical Pharmacology|October 8, 2014
The pharmacokinetics of metformin and concentrations of haemoglobin A1C and lactate in Indigenous and non-Indigenous Australians with type 2 diabetes mellitusJanna K Duong, Shaun S Kumar, Timothy J Furlong, et al.
Pageof 2